Literature DB >> 24314752

Diaphragmatic dysfunction in Collagen VI myopathies.

S Quijano-Roy1, S Khirani2, M Colella3, A Ramirez4, S Aloui5, S Wehbi6, A de Becdelievre7, R Y Carlier8, V Allamand9, P Richard7, V Azzi6, B Estournet6, B Fauroux10.   

Abstract

Collagen VI-related myopathies are hereditary disorders causing progressive restrictive respiratory insufficiency. Specific diaphragm involvement has been suggested by a drop in supine volumes. This pilot study aimed at characterizing the respiratory muscle phenotype in patients with COL6A1-3 genes mutations. Lung function, blood gases, muscle strength and respiratory mechanics were measured in 7 patients between 2002 and 2012. Patients were classified as Early-Severe (n = 3), Moderate-Progressive (n = 2) and Mild (n = 2) according to clinical disease presentation. Seven patients (aged 6-28) were evaluated. Forced vital capacity distinguished the Mild group (>60% predicted) from the two other groups (<50% predicted). This distinction was also possible using the motor function measure scale. Diaphragmatic dysfunction at rest was observed in all the Early-Severe and Moderate-Progressive patients. During a voluntary sniff maneuver diaphragmatic dysfunction was observed in all patients, as assessed by a negative gastric pressure. All patients had diaphragmatic fatigue assessed by a tension-time index over the threshold of 0.15. Diaphragmatic dysfunction during a maximal voluntary maneuver and diaphragmatic fatigue are constant features in Collagen VI myopathies. These observations can assist the diagnosis and should be taken in account for the clinical management, with the early detection of sleep-disordered breathing.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bethlem myopathy; COLVI-related myopathy; Diaphragm; Motor function measure scale; Respiratory function; Ullrich congenital muscular dystrophy; Whole body muscle magnetic resonance imaging

Mesh:

Substances:

Year:  2013        PMID: 24314752     DOI: 10.1016/j.nmd.2013.11.002

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  7 in total

1.  The value of respiratory muscle testing in a child with congenital muscular dystrophy.

Authors:  Sonia Khirani; Ivana Dabaj; Alessandro Amaddeo; Adriana Ramirez; Susana Quijano-Roy; Brigitte Fauroux
Journal:  Respirol Case Rep       Date:  2014-06-30

Review 2.  Genetic and Clinical Advances of Congenital Muscular Dystrophy.

Authors:  Xiao-Na Fu; Hui Xiong
Journal:  Chin Med J (Engl)       Date:  2017-11-05       Impact factor: 2.628

3.  Pneumothoraces in collagen VI-related dystrophy: a case series and recommendations for management.

Authors:  Kristin L Fraser; Scott Wong; A Reghan Foley; Sameer Chhibber; Carsten G Bönnemann; Daniel J Lesser; Carla Grosmann; Anne Rutkowski
Journal:  ERJ Open Res       Date:  2017-06-23

Review 4.  Non-invasive Ventilation in Children With Neuromuscular Disease.

Authors:  Brigitte Fauroux; Sonia Khirani; Lucie Griffon; Theo Teng; Agathe Lanzeray; Alessandro Amaddeo
Journal:  Front Pediatr       Date:  2020-11-16       Impact factor: 3.418

5.  Intrafamilial Phenotypic Variability of Collagen VI-Related Myopathy Due to a New Mutation in the COL6A1 Gene.

Authors:  Sergey N Bardakov; Roman V Deev; Raisat M Magomedova; Zoya R Umakhanova; Valérie Allamand; Corine Gartioux; Kamil Z Zulfugarov; Patimat G Akhmedova; Vadim A Tsargush; Angelina A Titova; Mikhail O Mavlikeev; Vadim L Zorin; Ekaterina N Chernets; Gimat D Dalgatov; Fedor A Konovalov; Artur A Isaev
Journal:  J Neuromuscul Dis       Date:  2021

6.  [Anesthesia for thoracic surgery in a female patient with Ullrich congenital muscular dystrophy].

Authors:  Thomas Hachenberg; Thorsten Walles; Eva Lücke; Thomas Schilling
Journal:  Anaesthesiologie       Date:  2022-05-30

7.  A TALEN-Exon Skipping Design for a Bethlem Myopathy Model in Zebrafish.

Authors:  Zlatko Radev; Jean-Michel Hermel; Yannick Elipot; Sandrine Bretaud; Sylvain Arnould; Philippe Duchateau; Florence Ruggiero; Jean-Stéphane Joly; Frédéric Sohm
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.